Test Price
1,400 AED✅ Home Collection Available
MDS FISH Panel (del(5q), del(7q), del(20q)) in UAE | 1,400 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MDS FISH Panel is a highly targeted cytogenetic test that uses Fluorescence In Situ Hybridization to detect the three most clinically significant chromosomal deletions — del(5q), del(7q), and del(20q) — in bone marrow or peripheral blood cells. This panel is essential for the diagnosis, risk stratification, and therapeutic monitoring of myelodysplastic syndromes (MDS), directly guiding 5‑azacytidine eligibility and transplantation decisions.
| Feature | Our MDS FISH Panel (Precision Testing) | Conventional Karyotyping (Alternative) |
|---|---|---|
| Precision / Resolution | Probes specific to 5q31, 7q31, 20q12; detects even low‑level clones | ~5 Mb resolution; misses small deletions and low‑percentage mosaicism |
| Methodology | Fluorescence In Situ Hybridization (FISH) on interphase nuclei or metaphase spreads | Giemsa‑banded metaphase analysis requiring dividing cells |
| Turnaround Time | 5‑7 Days | 10‑14 Days (often longer due to culture failure) |
| Sample Requirement | Bone Marrow (preferred) or Peripheral Blood – transport immediately | Bone Marrow only; viable cells mandatory |
Physician Insight & Safety Protocols
"A positive FISH finding for any of these deletions must always be correlated with peripheral blood counts, bone marrow morphology, and clinical symptoms. This test provides powerful prognostic information, but only your treating haematologist can interpret it within the full picture of your health." — Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA License 61713011
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. This panel is part of a comprehensive evaluation and does not replace ongoing treatment discussions.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: This test requires a valid doctor’s prescription. It is not applicable for elective surgery clearance, routine pregnancy screening, or travel‑related health checks.
- Sample Rejection: Specimens not transported immediately or arriving clotted/haemolysed will be rejected; a recollection will be arranged.
- Emergency Red Flags – Go to ER if you experience: sudden severe bleeding or bruising, fever >38.5 °C with neutropenia, acute shortness of breath, or altered consciousness. These may signal disease progression or treatment‑related complications.
Patient FAQ & Clinical Guidance
1. What is the MDS FISH Panel and why is it performed?
MDS FISH Panel precisely detects chromosome 5q, 7q, and 20q deletions in bone marrow cells for diagnosis. This identifies high‑risk MDS subtypes that require aggressive treatment, including stem cell transplantation, and confirms eligibility for lenalidomide therapy in del(5q) patients.
2. How should I prepare for the bone marrow or blood collection?
No fasting is required, but bring your doctor’s prescription and list of current medications for our phlebotomist. A hospital‑grade cold‑chain collection ensures sample viability; you will be informed about the exact time slot and any anticoagulant adjustments specific to your case.
3. What do positive del(5q), del(7q), or del(20q) results mean?
A positive deletion result indicates an acquired clonal cytogenetic abnormality associated with myelodysplastic syndrome, influencing prognosis significantly. For example, isolated del(5q) often predicts a better response to lenalidomide, whereas del(7q) or complex karyotype including these deletions may indicate higher‑risk disease requiring immediate haematology consultation.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
- This test is conducted under DHA Facility License No. 1143, ensuring compliance with Dubai Healthcare City standards.
- All patient data is handled in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Physical Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | MDS FISH Panel (del(5q), del(7q), del(20q)) |
| Price (AED) | 1,400 AED |
| Turnaround Time | 5-7 Days |
| Sample Type / Matrix | Bone Marrow (preferred) or Peripheral Blood – Hospital Extraction Only. Collection conducted strictly within an accredited hospital facility; mobile home phlebotomy disabled for safety. |
| Methodology Used | Fluorescence In Situ Hybridization (FISH) |
| ICD-10-CM Code | D46.20 |
| LOINC Code | 86903-2 |
| DHA Facility License & Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians